Follow-The-Filings

Security

BMRN

Biomarin Pharmaceutical Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

17 owners 2 new 2 exits max 1.1% (Andreas Halvorsen - Vikin...)

grid → activity →
owners 17
max % 1.1%
tracked value $3.9B
qoq N 2 A 5 R 8 E 2

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Andreas Halvorsen - Viking Global Investors LP 2026 Q1 1.1% Add +0.16 pp 7,062,077 $399M hist
Torray Investment Partners LLC 2026 Q2 stale 0.6% Reduce -0.05 pp 77,705 $4M hist
Dodge & Cox 2026 Q1 0.5% Reduce -0.02 pp 14,561,759 $823M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.2% Add -0.01 pp 7,676,541 $429M hist
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.1% New 0.1% 1,362,752 $77M hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.1% Add +0.06 pp 1,199,206 $68M hist
Renaissance Technologies LLC 2026 Q1 0.1% Reduce -0.03 pp 1,024,871 $58M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.1% Reduce -0.01 pp 3,010,308 $170M hist
Norges Bank 2025 Q4 stale 0.1% Exit -0.05 pp 7,531,080 $448M hist
Ray Dalio - Bridgewater Associates, LP 2026 Q1 0.1% Reduce 0.00 pp 206,911 $12M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add +0.03 pp 4,512,634 $255M hist
Joel Greenblatt - Gotham Asset Management, LLC 2026 Q1 0.0% Reduce -0.03 pp 174,091 $10M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Reduce 0.00 pp 18,127,847 $1.1B hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Reduce -0.02 pp 282,460 $16M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit -0.01 pp 69,766 $4M hist
Ken Fisher - Fisher Asset Management, LLC 2026 Q1 0.0% Add 0.00 pp 35,480 $2M hist
Natixis Advisors, LLC 2026 Q1 0.0% New 0.0% 13,617 $769 hist
Marshall Wace - Marshall Wace, LLP exited 2026 Q1 last 2025 Q4 0.0% Exit -0.02 pp 310,891 $18M hist
Ancora Advisors LLC exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 702 $42 hist

17 current · 2 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.42B $2.85B $3.22B
Gross profit * $1.9B $2.27B $2.5B
Gross margin * 78.7% 79.7% 77.7%
Net income $167.64M $426.86M $348.9M
Net margin * 6.9% 15.0% 10.8%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $2.96B $3.23B $3.95B
Total non-current assets * $3.89B $3.76B $3.64B
Total assets $6.84B $6.99B $7.59B
Total current liabilities $1.18B $606.99M $759.03M
Total non-current liabilities * $713.03M $723.96M $747.99M
Total equity $4.95B $5.66B $6.09B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $159.26M $572.84M $827.99M
Cash from investing -$111.24M $136.49M -$414.24M
Cash from financing -$18.73M -$526.45M -$42.39M
Net change in cash $30.6M $187.72M $368.84M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders